Answers are grounded in this paper and cite their sources.
receptor antagonist bicuculline methiodide reversed the stimulation-induced antinociception after five ESIs. ESI increased GAD65 levels in pIC but did not interfere with GABA, glutamate or glycine levels. No changes in GFAP immunoreactivity were found in this work. Altogether, the results indicate the efficacy of repetitive ESI for the treatment of experimental neuropathic pain and suggest a potential influence of pIC in regulating pain pathways partially through modulating GABAergic signaling.
No takes yet. Share an insight, caveat, or question.
Matielo et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: